{"product_id":"gl-3-reta-weight-loss-molecule-and-consultation-40mg-2ml","title":"GL-3 (RETA) Weight Loss Molecule and Consultation - 40mg\/2mL","description":"\u003ch1\u003eGL-3 Molecule (RETA)\u003c\/h1\u003e\n\u003ch1\u003e(Prescription Only) – 40mg\u003c\/h1\u003e\n\u003ch2\u003eTriple-Incretin Therapy for Fat Loss, Appetite Control \u0026amp; Metabolic Optimization\u003c\/h2\u003e\n\u003chr\u003e\n\u003ch1\u003eFormulation\u003c\/h1\u003e\n\u003ch2\u003eGL-3 Core 40\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1 × 40mg GL-3 Vial\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach vial contains:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e40mg GL-3\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e2mL total volume\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eConcentration:\u003c\/strong\u003e \u003cstrong\u003e40mg \/ 2mL (20mg\/mL)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eTotal Package Contents:\u003c\/strong\u003e \u003cstrong\u003e40mg GL-3 (2mL total)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eClassification:\u003c\/strong\u003e Prescription Only – Requires Provider Consultation \u0026amp; Approval\u003c\/p\u003e\n\u003chr\u003e\n\u003ch1\u003eWhat Is GL-3 Therapy?\u003c\/h1\u003e\n\u003cp\u003eGL-3 is a prescription triple-incretin therapy that activates three key metabolic pathways involved in appetite regulation, metabolism, and fat utilization:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGLP-1 (Glucagon-Like Peptide-1)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGIP (Glucose-Dependent Insulinotropic Polypeptide)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGlucagon Receptor\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eUnlike traditional weight-loss therapies that primarily suppress appetite, GL-3 works through multiple metabolic pathways to improve body composition by reducing caloric intake while simultaneously increasing energy expenditure and promoting fat oxidation.\u003c\/p\u003e\n\u003cp\u003ePotential benefits include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eSignificant appetite suppression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAccelerated fat loss\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eImproved insulin sensitivity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIncreased calorie expenditure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eEnhanced fat oxidation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eImproved metabolic flexibility\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eLong-term body composition improvements\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eGL-3 represents the most advanced generation of incretin therapy and is intended for provider-directed metabolic optimization and sustained fat loss.\u003c\/p\u003e\n\u003cp\u003eAll GL-3 products require clinical consultation and prescription approval prior to dispensing.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch1\u003e🔬 Research-Based Mechanisms\u003c\/h1\u003e\n\u003ch2\u003e🔥 Triple-Incretin Activation for Superior Fat Loss\u003c\/h2\u003e\n\u003cp\u003eGL-3 activates the GLP-1, GIP, and glucagon receptors simultaneously, creating complementary effects on appetite regulation, insulin sensitivity, and energy expenditure that exceed those seen with single-pathway therapies.\u003c\/p\u003e\n\u003cp\u003ePotential benefits include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eReduced hunger\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIncreased satiety\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGreater fat oxidation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIncreased calorie expenditure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eImproved preservation of lean body mass during weight loss\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eJastreboff et al., 2023 (NEJM)\u003c\/strong\u003e demonstrated average body-weight reductions approaching \u003cstrong\u003e24.2% over 48 weeks\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e🩸 Improved Glycemic Control \u0026amp; Insulin Sensitivity\u003c\/h2\u003e\n\u003cp\u003eGL-3 enhances glucose regulation by improving insulin responsiveness while reducing fasting glucose levels and HbA1c.\u003c\/p\u003e\n\u003cp\u003ePotential benefits include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eImproved insulin sensitivity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eReduced fasting glucose\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eImproved metabolic health\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eBetter nutrient partitioning\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFrias et al., 2023 (Diabetes Care)\u003c\/strong\u003e demonstrated significant improvements in glycemic control.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e🧠 Appetite Suppression \u0026amp; Craving Control\u003c\/h2\u003e\n\u003cp\u003eGL-3 acts on appetite centers within the brain to reduce hunger while decreasing food reward signaling.\u003c\/p\u003e\n\u003cp\u003eMany patients report:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eLess frequent hunger\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eEarlier fullness during meals\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eReduced cravings\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eEasier adherence to calorie reduction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch2\u003e🧬 Increased Fat Oxidation \u0026amp; Energy Expenditure\u003c\/h2\u003e\n\u003cp\u003eActivation of the glucagon receptor increases the body's utilization of stored fat while helping maintain metabolic rate during weight loss.\u003c\/p\u003e\n\u003cp\u003ePotential benefits include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eIncreased fat utilization\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHigher daily calorie expenditure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eImproved metabolic efficiency\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eEnhanced body composition\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch1\u003e⚕️ Clinical Access \u0026amp; Provider Oversight\u003c\/h1\u003e\n\u003cp\u003eGL-3 therapy requires ongoing provider supervision.\u003c\/p\u003e\n\u003cp\u003eTreatment includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eInitial consultation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePrescription approval\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIndividualized dosing plan\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eTitration based on response\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eFollow-up monitoring\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRecommended laboratory evaluation may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eHbA1c\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eFasting glucose\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eComprehensive metabolic panel (CMP)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eLipid panel\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch1\u003e💉 Dosing Protocol (GL-3 Core 40)\u003c\/h1\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003c\/th\u003e\n\u003cth\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTotal Medication\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e40mg GL-3\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackage Contents\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1 × 40mg vial\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eConcentration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e40mg \/ 2mL (20mg\/mL)\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDosing Equivalency\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5 units = 1mg GL-3\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePatient Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEstablished higher-dose patients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eContinuation Therapy\u003c\/h2\u003e\n\u003cp\u003eGL-3 Core 40 is intended for patients who have already completed their initial titration and are established on higher weekly dosing.\u003c\/p\u003e\n\u003cp\u003eThis formulation is designed to reduce refill frequency while maintaining consistent therapy—not to extend treatment duration.\u003c\/p\u003e\n\u003cp\u003eTypical weekly dosing ranges include:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eWeekly Dose\u003c\/th\u003e\n\u003cth align=\"right\"\u003eInjection Volume\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e5mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e25 units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e30 units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e35 units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e40 units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e45 units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10mg\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e50 units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eYour provider will individualize dosing based on treatment response, body composition goals, and medication tolerance.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eDose Adjustments\u003c\/h2\u003e\n\u003cp\u003eRemain on the current dose while progress continues.\u003c\/p\u003e\n\u003cp\u003eYour provider may recommend increasing by \u003cstrong\u003e5 units (1mg)\u003c\/strong\u003e if:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eWeight loss plateaus for two or more consecutive weeks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAppetite suppression significantly diminishes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eTreatment continues to be well tolerated\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf side effects occur:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eReduce by \u003cstrong\u003e5 units (1mg)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eRemain at the lower dose until symptoms improve\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eResume upward titration only under provider guidance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch2\u003eAdministration\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute:\u003c\/strong\u003e Subcutaneous injection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePreferred Site:\u003c\/strong\u003e Abdomen\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eRotate injection sites regularly.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch1\u003eIdeal Use\u003c\/h1\u003e\n\u003cp\u003eGL-3 Core 40 is specifically designed for patients requiring \u003cstrong\u003ehigher weekly dosing\u003c\/strong\u003e after successful titration through lower-dose therapy.\u003c\/p\u003e\n\u003cp\u003eRather than purchasing multiple smaller vials, patients can maintain uninterrupted treatment using a single higher-concentration vial.\u003c\/p\u003e\n\u003cp\u003eBecause this formulation is intended for established higher-dose therapy, most patients will utilize the entire vial within approximately \u003cstrong\u003e45–60 days\u003c\/strong\u003e, supporting both treatment continuity and appropriate handling after first puncture.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eApproximate Treatment Duration\u003c\/h2\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eWeekly Dose\u003c\/th\u003e\n\u003cth align=\"right\"\u003eWeekly Units\u003c\/th\u003e\n\u003cth align=\"right\"\u003eApproximate Duration\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e5mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e25 units\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e~56 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e6mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e30 units\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e~47 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e7mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e35 units\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e~40 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e8mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e40 units\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e~35 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e9mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e45 units\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e~31 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e50 units\u003c\/td\u003e\n\u003ctd align=\"right\"\u003e~28 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eActual duration will vary based on individualized provider-directed dosing.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch1\u003eTypical Program Length\u003c\/h1\u003e\n\u003cp\u003eGL-3 is commonly incorporated into a \u003cstrong\u003e3–12 month provider-guided metabolic optimization program\u003c\/strong\u003e, with reassessment every \u003cstrong\u003e4–8 weeks\u003c\/strong\u003e to evaluate progress, adjust dosing, and determine appropriate cycling strategies.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch1\u003eCompatible Therapy Stacks\u003c\/h1\u003e\n\u003ch3\u003eKPV\u003c\/h3\u003e\n\u003cp\u003eSupports gastrointestinal health, gut barrier integrity, and inflammatory balance.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eTesamorelin\u003c\/h3\u003e\n\u003cp\u003eSupports body composition by stimulating endogenous growth hormone release, helping preserve lean muscle while reducing visceral abdominal fat.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eMOTS-C\u003c\/h3\u003e\n\u003cp\u003eEnhances mitochondrial energy production, metabolic flexibility, insulin sensitivity, and exercise performance while supporting healthy fat utilization.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eGHK-Cu\u003c\/h3\u003e\n\u003cp\u003eSupports tissue repair, recovery, and overall regenerative health.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch1\u003e📦 Every Order Includes\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e1 × 40mg GL-3 vial (2mL)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eInsulin syringes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAlcohol swabs\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSharps disposal bag\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePrinted dosing, storage, mixing (if applicable), and injection guide\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eOngoing access to a licensed prescribing provider for treatment support\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch1\u003e📧 Questions?\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003ca href=\"mailto:Admin@Propeptides.com\"\u003eAdmin@Propeptides.com\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e480-400-6225\u003c\/strong\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003ch1\u003e🛡️ Advanced Fat Loss. Triple-Pathway Precision. Clinical Oversight.\u003c\/h1\u003e\n\u003cp\u003eGL-3 Core 40 is formulated for patients who have progressed to higher-dose therapy and require a more concentrated monthly supply to maintain momentum toward their body composition goals. By simultaneously activating the GLP-1, GIP, and glucagon receptors, GL-3 supports appetite regulation, increased fat oxidation, improved insulin sensitivity, and greater energy expenditure.\u003c\/p\u003e\n\u003cp\u003eDesigned for experienced patients utilizing higher weekly doses, GL-3 Core 40 delivers convenient dosing flexibility in a single concentrated vial while maintaining comprehensive provider oversight. When paired with individualized nutrition, resistance training, and regular follow-up, it provides an effective tool for achieving sustainable improvements in body composition and long-term metabolic health.\u003c\/p\u003e","brand":"Pro Peptides","offers":[{"title":"Default Title","offer_id":49226844635395,"sku":null,"price":799.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0769\/7848\/7555\/files\/Reta40.png?v=1783457453","url":"https:\/\/www.propeptides.com\/products\/gl-3-reta-weight-loss-molecule-and-consultation-40mg-2ml","provider":"Pro Peptides","version":"1.0","type":"link"}